+1 915 229 3004 (U.S.) |
+44 7452 242832 (U.K.)

A comprehensive report spanning 443 pages reveals that the global depression treatment market is poised to surpass $10.11 billion in 2022, with a projected CAGR of 5.21%, reaching $16.81 billion by 2032. Drugs dominate the market, contributing over 99.41% of the demand share in 2021.
· Market Value 2021: $9.71 Billion
· Market Value 2022: $10.11 Billion
· Market Value 2032: $16.8 1Billion
· CAGR (2022-2032): 5.21%
· Top 5 Countries Market Share: 58.91%
· Depression Treatment Market Share of Global Behavioral Health Market: 7.61%
The World Health Organization (WHO) notes a 13.1% rise in mental health conditions globally in the last decade, and the USA Department of Health and Human Services reports a significant prevalence of major depressive episodes among adolescents in 2020.
Sales of depression treatment surged at a CAGR of 3.41% from 2012 to 2021, driven by increased awareness and the growing need for antidepressants. The pandemic has further amplified mental health issues, leading to a heightened demand for anxiety and depression treatments.
Ongoing developments in antidepressants, such as SSRIs and SNRIs, coupled with regulatory approvals, contribute positively to the market. The report anticipates a 5.21% CAGR in sales from 2022 to 2032.
Governments worldwide are boosting funding for mental health services, emphasizing the need for quality treatments and affordable healthcare policies. The rising demand for enhanced mental fitness is creating new prospects for depression treatments, aligning with improved healthcare infrastructure and increased government medical expenditure.
Challenges include a shortage of well-trained specialists, the impending release of generic equivalents, and the social stigma associated with mental illnesses, hindering effective therapy and leading to self-stigmatization.
Key players are focusing on acquisitions and expansion to develop unique assets. Examples include AbbVie's acquisition of Syndesi Therapeutics and Teva Pharmaceuticals' strategic focus on the Japanese market.
· Forecast Period: 2012 to 2032
· Historical Data: Available for 2022 to 2032
· Market Analysis: US$ Million for Value
· Key Regions Covered: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa
· Key Countries Covered: USA, Canada, Brazil, Mexico, Germany, Italy, France, UK, Spain, China, Japan, South Korea, India, GCC countries, Turkey, South Africa, and more.
· Key Market Segments: Products, Diseases, Distribution Channels, and Regions
· Viatris
· Sunovian Pharmaceuticals
· AbbVie Inc.
· Jubilant Generics Limited
· Sanis Health Inc.
· Abbott Laboratories
· Aurobindo Pharma
· Torrent Pharmaceuticals
· Teva Pharmaceuticals
A comprehensive report spanning 443 pages reveals that the global depression treatment market is poised to surpass $10.11 billion in 2022.
The global market is projected to grow at a CAGR of 5.21% during the forecast period, 2023-2032.


Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.

Report Code :
RL65502
Published on :
Upcoming
Request a Free Sample Report